Literature DB >> 21779229

High-Grade Breast Epithelioid Angiosarcoma Secondary to Radiotherapy Metastasizing to the Contralateral Lymph Node: Unusual Presentation and Potential Pitfall.

Ana Luísa Cunha1, Isabel Amendoeira.   

Abstract

BACKGROUND: Breast angiosarcoma is a rare disease occurring as primary tumour or secondary to lymphoedema or radiotherapy. The more frequent use of breast-conserving therapy and radiotherapy for breast carcinoma explains the increasing diagnosis of these tumours. CASE REPORT: We report a case of a breast epithelioid angiosarcoma which metastasized to the contralateral axillary lymph node, occurring 4 years after breast-conserving therapy with axillary lymph node dissection and radiotherapy. The patient presented skin lesions and an axillary lump (clinically diagnosed as carcinoma relapse and lymph node metastasis). Fine-needle cytology on both lesions and a core needle biopsy of the axillary lump were carried out. Differential diagnosis included carcinoma, malignant melanoma, and angiosarcoma. Immunohistochemistry confirmed the diagnosis of angiosarcoma.
CONCLUSIONS: Breast angiosarcoma is a challenge - clinically, radiologically and pathologically - and requires a high index of suspicion in susceptible patients.

Entities:  

Year:  2011        PMID: 21779229      PMCID: PMC3132971          DOI: 10.1159/000329323

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  18 in total

1.  Angiosarcoma of the Breast: Immunohistochemical Demonstration of Steroid Receptors and Literature Review.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature.

Authors:  Alberto Luini; Giovanna Gatti; Jack Diaz; Edoardo Botteri; Eliegina Oliveira; Rafaela Cecilio Sahium de Almeida; Paolo Veronesi; Mattia Intra; Gianmatteo Pagani; Paola Naninato; Giuseppe Viale
Journal:  Breast Cancer Res Treat       Date:  2006-11-18       Impact factor: 4.872

Review 3.  Angiosarcoma after breast-conserving therapy.

Authors:  Alan T Monroe; Steven J Feigenberg; Nancy Price Mendenhall
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

4.  Risk of angiosarcoma following breast conservation: a clinical alert.

Authors:  John G West; Azhar Qureshi; Justin E West; Monique Chacon; M Linda Sutherland; Bijan Haghighi; Judith Harrison
Journal:  Breast J       Date:  2005 Mar-Apr       Impact factor: 2.431

Review 5.  Epithelioid soft tissue tumors.

Authors:  A Paolo Dei Tos; Andrew J Wagner; Piergiorgio Modena; Alessandro Comandone; Serge Leyvraz
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

6.  Fine-needle aspiration biopsy of postradiation epithelioid angiosarcoma of breast.

Authors:  Z Vesoulis; C Cunliffe
Journal:  Diagn Cytopathol       Date:  2000-03       Impact factor: 1.582

7.  Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy.

Authors:  Manisha Palta; Christopher G Morris; Stephen R Grobmyer; Edward M Copeland; Nancy P Mendenhall
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

8.  Postirradiation epithelioid angiosarcoma of the breast: a case report with immunohistochemical and electron microscopic study.

Authors:  In Sook Seo; Kyung-Whan Min
Journal:  Ultrastruct Pathol       Date:  2003 May-Jun       Impact factor: 1.094

9.  Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma.

Authors:  M P Stokkel; H L Peterse
Journal:  Cancer       Date:  1992-06-15       Impact factor: 6.860

10.  The risk of angiosarcoma following primary breast cancer.

Authors:  W Cozen; L Bernstein; F Wang; M F Press; T M Mack
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  1 in total

1.  Primary Angiosarcoma of the Breast after Bilateral Breast Reduction.

Authors:  Justus Philip; Elizabeth Bender; Kristy Waite
Journal:  Case Rep Surg       Date:  2018-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.